Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brooke Bernhardt

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Hematologic Malignancy Reports|May 20, 2016
Bending the Cost Curve in Childhood CancerHeidi Russell, M Brooke Bernhardt
Pediatric Blood & Cancer|November 19, 2016
Using decision modeling to guide drug allocation during a shortageHeidi V Russell, M Brooke Bernhardt, Stacey Berg
Pediatric Blood & Cancer|September 5, 2009
Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanomaM Brooke Bernhardt, M John Hicks, Alberto S Pappo
Pediatric Blood & Cancer|December 31, 2020
The Best Pharmaceuticals for Children Act and Pediatric Research Equity Act reach the age of majority-An oncology perspectiveM Brooke Bernhardt, Holly Lindsay, Wendy Allen-Rhoades, et al.
Pediatric Blood & Cancer|December 31, 2013
Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolismJulienne Brackett, Eric S Schafer, Daniel H Leung, et al.
Pediatric Blood & Cancer|January 17, 2009
Oral iron chelation and the treatment of iron overload in a pediatric hematology centerJean L Raphael, M Brooke Bernhardt, Donald H Mahoney, et al.
The Journal of Emergency Medicine|October 12, 2016
Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of HydrocodoneCorrie E Chumpitazi, Chris A Rees, Elizabeth A Camp, et al.
Cancer Chemotherapy and Pharmacology|October 21, 2017
Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensificationCasey L McAtee, Netta Schneller, Julienne Brackett, et al.
Pediatric Blood & Cancer|October 15, 2017
Evaluation of aprepitant for acute chemotherapy-induced nausea and vomiting in children and adolescents with acute lymphoblastic leukemia receiving high-dose methotrexateFemi Felix-Ukwu, Kate Reichert, M Brooke Bernhardt, et al.
Leukemia & Lymphoma|December 18, 2019
Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL)Austin J Stuckert, Eric S Schafer, M Brooke Bernhardt, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Hematologic Malignancy Reports|May 20, 2016
Bending the Cost Curve in Childhood CancerHeidi Russell, M Brooke Bernhardt
Pediatric Blood & Cancer|November 19, 2016
Using decision modeling to guide drug allocation during a shortageHeidi V Russell, M Brooke Bernhardt, Stacey Berg
Pediatric Blood & Cancer|September 5, 2009
Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanomaM Brooke Bernhardt, M John Hicks, Alberto S Pappo
Pediatric Blood & Cancer|December 31, 2020
The Best Pharmaceuticals for Children Act and Pediatric Research Equity Act reach the age of majority-An oncology perspectiveM Brooke Bernhardt, Holly Lindsay, Wendy Allen-Rhoades, et al.
Pediatric Blood & Cancer|December 31, 2013
Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolismJulienne Brackett, Eric S Schafer, Daniel H Leung, et al.
Pediatric Blood & Cancer|January 17, 2009
Oral iron chelation and the treatment of iron overload in a pediatric hematology centerJean L Raphael, M Brooke Bernhardt, Donald H Mahoney, et al.
The Journal of Emergency Medicine|October 12, 2016
Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of HydrocodoneCorrie E Chumpitazi, Chris A Rees, Elizabeth A Camp, et al.
Cancer Chemotherapy and Pharmacology|October 21, 2017
Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensificationCasey L McAtee, Netta Schneller, Julienne Brackett, et al.
Pediatric Blood & Cancer|October 15, 2017
Evaluation of aprepitant for acute chemotherapy-induced nausea and vomiting in children and adolescents with acute lymphoblastic leukemia receiving high-dose methotrexateFemi Felix-Ukwu, Kate Reichert, M Brooke Bernhardt, et al.
Leukemia & Lymphoma|December 18, 2019
Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL)Austin J Stuckert, Eric S Schafer, M Brooke Bernhardt, et al.
Pageof 5